EUMETSAT Moodle
hurricanes
VLP-based vaccines (Virus-Like Particle vaccines) are a type of vaccine that utilizes engineered virus-like particles to stimulate an immune response without using live viruses. These particles mimic the structure of actual viruses but lack their genetic material, making them non-infectious and safe for vaccination purposes.
Key Features of VLP-based Vaccines:
Composition:
- VLPs are made from viral proteins that self-assemble into structures resembling the native virus but without the viral genome.
- They are typically produced in recombinant systems, such as yeast, insect, or mammalian cells, which express viral structural proteins.
Mechanism of Action:
- When administered, VLPs are recognized by the immune system as foreign particles, stimulating both humoral (antibody-mediated) and cellular (T-cell) immunity.
- The immune system then produces antibodies against the viral proteins present on the VLPs, providing immunity against future infections by the actual virus.
Advantages:
- Safety: Since VLPs do not contain live viral genetic material, they cannot cause infection, making them safer than live-attenuated vaccines.
- Immune Response: They effectively stimulate a strong immune response, particularly the production of neutralizing antibodies.
- No Risk of Reversion: Unlike live-attenuated vaccines, VLP-based vaccines carry no risk of reverting to a virulent form.
- Stability: VLP vaccines are generally more stable than live viruses, which may require refrigeration or special handling.
Applications:
- Human Vaccines: VLP-based vaccines have been successfully developed and approved for the prevention of several viral diseases. A notable example is the HPV vaccine (Gardasil), which protects against human papillomavirus, a major cause of cervical cancer.
- Veterinary Vaccines: VLP-based vaccines are also used in veterinary medicine, such as vaccines for feline leukemia virus (FeLV) and other animal diseases.
- Research and Development: VLPs are also used to study viral proteins and their interactions with the immune system, advancing our understanding of viral pathogenesis.